Anesthetics

PreclinicalSmall molecule

MMedical University of Vienna

Anesthetics is one of 50 small molecule programs targeting Obese Patients. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Obese PatientsWithdrawn

ESSUnknown status

Obese PatientsPreclinical

Withdrawn

ESSPreclinical

Unknown status

Competition

Competitive Landscape

56 competitors in ESS

#DrugCompanyPhaseTrials

Lexapro

AbbVie

Approved

7 2

Proamatine

Takeda

Approved

2 3

Quviviq

Idorsia Pharmaceuticals Ltd.

Approved

1 4

Opdualag

Bristol-Myers Squibb

Phase 2

2 5

Opdivo

Bristol-Myers Squibb

Phase 2

2 6

Darzalex

Johnson & Johnson

Phase 2

1 7

Revlimid

KKaruna Therapeutics, Inc., a Bristol Myers Squibb company

Phase 2

1 8

Kyprolis

VVirionyx Corporation Limited

Phase 2

1 9

Decadron

AAspen Global Incorporated

Phase 2

1 10

Mineral Trioxide Aggregate

JJordan University of Science and Technology

Phase 3

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Obese Patients1 trial

Modified Rapid Sequence Induction in Morbidly Obese Patients

Withdrawn·MMedical University of Vienna·N/A·NCT03239236

ESS1 trial

Assessing Covert Consciousness in Unresponsive Patients

Unknown status·UUniversity of Michigan·N/A·NCT02659228·60 enrolled

Heart Rate Variability1 trial

Effects of Propofol Induction Anaesthesia on the Heart Rate Variability

Completed·NNational Central University··NCT03613961·30 enrolled

Sources

References

[1]
ClinicalTrials.gov — 3 trial records for Anesthetics. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Anesthetics compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Anesthetics. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Medical University of Vienna company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: MMedical University of Vienna

Anesthetics

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Obese Patients1 trial

ESS1 trial

Heart Rate Variability1 trial

References

Drug Info

Quick Facts

Related News